• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New Oracle Cloud Services Help Pharmas Accelerate Clinical Trial Site Feasibility Assessment and Patient Recruitment

    10/29/24 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Developments are the latest in Oracle's commitment to bridge the gap between clinical research and patient care to help speed the development of and access to breakthrough treatments   

    NASHVILLE, Tenn., Oct. 29, 2024 /PRNewswire/ -- Oracle Health Summit -- To help life sciences organizations accelerate and reduce the cost and complexity of clinical trials so they can get lifesaving treatments to market faster, Oracle Life Sciences today announced Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services. Running on Oracle Cloud Infrastructure (OCI), the new Oracle Life Sciences services benefit from best-in-class security and trust in handling and storing Protected Health Information in compliance with HIPAA regulations. In addition, OCI's high performance and availability mean these new solutions, coupled with Oracle's Real World Data assets and life science and clinical applications, help pharmaceutical companies, CROs and researchers to select clinical trial sites and recruit patients more quickly.

    (PRNewsfoto/Oracle)

    "Patient recruitment is the cornerstone of any clinical trial, but identifying the right sites and recruiting the right patients at scale is difficult, time-consuming, and costly," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Our new site feasibility and patient recruitment cloud services are an example of how Oracle's extensive expertise in life sciences and healthcare are bridging the gap between clinical research and patient care. We can provide insights based on our secure, authorized, and vast Electronic Health Record data that helps sponsors and CROs to intelligently select clinical trial sites and enable site study teams to identify and enroll qualified patients more efficiently and effectively."

    According to Deloitte research1, patient recruitment accounts for 32% of clinical trial costs, making it the largest expense in the process. Additionally, $1.9 billion is spent on recruitment annually,2 even though 72% of trial participants are already patients at a site. Oracle Site Feasibility and Oracle Patient Recruitment can help life sciences organizations overcome these challenges and dramatically reduce the cost of running clinical trials.

    Through the existing Study Startup solution and Oracle's extensive deidentified Electronic Health Record (EHR) data from participating healthcare systems, Oracle Site Feasibility Cloud Service enables life sciences organizations to quickly and easily identify the most advantageous sites for their clinical trials. Within activated clinical trial sites, Oracle Patient Recruitment Cloud Service can increase enrollment efficiency by informing authorized study teams of identified patients within their health system who could potentially meet trial criteria based on their clinical profile.

    Activate sites faster and accelerate study timelines

    With Oracle Site Feasibility, life science organizations can accelerate the site-selection process and have more visibility into untapped sites. The new service enables life science organizations to more quickly find viable clinical trial site locations by surfacing trial-specific eligible and partially eligible patients from participating healthcare facilities. This solution uses Oracle's deidentified EHR clinical data to run feasibility queries across patient records, analyzing key data points, such as past site performance and qualified patients per site. This data granularity helps life science organizations to intelligently select sites with the highest volume of potential eligible patients.

    Recruit the right patients more quickly

    Oracle Patient Recruitment is available globally for life sciences customers to help activate sites faster and provide deeper patient insights to help study teams be more aware of any retention or dropout risks and recruit the right patients for the trial. It uses Health Data Intelligence (HDI) as its underlying technology infrastructure to surface data directly from the EHR and identify eligible and partially eligible patients for potential trial participation.

    Oracle Patient Recruitment calculates an eligibility score for qualified patients and provides important insights to the study team about why a patient qualifies for a trial or where they may fall short. This level of detail lets study teams quickly identify what next steps should be taken with the trial candidate and eliminates time wasted searching for additional context in the medical record. Oracle Patient Recruitment also incorporates health system registration and scheduling data, giving study teams visibility to upcoming and past appointment details. Using these additional insights, the study team can customize a visit schedule based on the patient's unique situation to help ensure the patient does not drop out – another step in putting the patient's care first. 

    For more information about Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services, visit: https://www.oracle.com/life-sciences/

    To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

    1 Taylor K, Properzo, F, et al. Intelligent clinical trials. Deloitte Centre for Health Insights. 2020. https://www2.deloitte.com/content/dam/insights/us/articles/22934_intelligent-clinical-trials/DI_Intelligent-clinical-trials.pdf

    2
    Idnay B, Fang Y, Butler A, et al. Uncovering key clinical trial features influencing recruitment. J Clin Transl Sci. 2023 Sep 4;7(1):e199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565197/

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/new-oracle-cloud-services-help-pharmas-accelerate-clinical-trial-site-feasibility-assessment-and-patient-recruitment-302289032.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What are the new services announced by Oracle Life Sciences?

      Oracle has launched new services named Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services to aid life sciences organizations in accelerating clinical trials and reducing costs.

    • How does Oracle Site Feasibility Cloud Service assist organizations?

      The Oracle Site Feasibility Cloud Service helps organizations quickly identify the best sites for clinical trials, leveraging deidentified Electronic Health Record data.

    • What percentage of clinical trial costs is attributed to patient recruitment?

      Patient recruitment accounts for 32% of clinical trial costs, which is the largest single expense in the clinical trial process.

    • What is the primary goal of the Oracle's new clinical trial services?

      The new services aim to improve efficiency in selecting clinical trial sites and rapidly recruiting suitable patients to ensure timely access to treatments.

    • What technology does the Oracle Patient Recruitment Cloud Service utilize to identify qualified patients?

      Oracle Patient Recruitment uses Health Data Intelligence technology to analyze patient records and calculate eligibility scores for potential trial candidates.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    10/9/2025$365.00Outperform
    Robert W. Baird
    9/25/2025$175.00Sell
    Rothschild & Co Redburn
    9/10/2025$410.00Neutral → Buy
    Citigroup
    9/10/2025$368.00Neutral → Buy
    BofA Securities
    9/10/2025$275.00 → $345.00Outperform
    BMO Capital Markets
    9/9/2025$245.00 → $275.00Outperform
    BMO Capital Markets
    7/17/2025$300.00Sector Outperform
    Scotiabank
    7/10/2025$270.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $ORCL
    SEC Filings

    View All

    Amendment: SEC Form 8-K/A filed by Oracle Corporation

    8-K/A - ORACLE CORP (0001341439) (Filer)

    10/6/25 4:15:26 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFA14A filed by Oracle Corporation

    DEFA14A - ORACLE CORP (0001341439) (Filer)

    9/26/25 5:21:07 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Oracle Corporation

    DEF 14A - ORACLE CORP (0001341439) (Filer)

    9/26/25 5:19:41 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Robert W. Baird initiated coverage on Oracle with a new price target

    Robert W. Baird initiated coverage of Oracle with a rating of Outperform and set a new price target of $365.00

    10/9/25 8:28:15 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Rothschild & Co Redburn initiated coverage on Oracle with a new price target

    Rothschild & Co Redburn initiated coverage of Oracle with a rating of Sell and set a new price target of $175.00

    9/25/25 8:33:44 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by Citigroup with a new price target

    Citigroup upgraded Oracle from Neutral to Buy and set a new price target of $410.00

    9/10/25 8:06:16 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Kehring Douglas A claimed ownership of 70,750 shares (SEC Form 3)

    3 - ORACLE CORP (0001341439) (Issuer)

    10/1/25 5:18:27 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    New insider Hura Mark claimed ownership of 254,077 shares (SEC Form 3)

    3 - ORACLE CORP (0001341439) (Issuer)

    10/1/25 5:14:48 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Seligman Naomi O sold $641,958 worth of shares (2,222 units at $288.91) and gifted 1,406 shares, decreasing direct ownership by 12% to 27,819 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    9/30/25 9:03:44 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Health Systems Simplify Secure Data Exchange with Oracle Health

    New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr

    10/9/25 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Intelligent Communications Orchestration Network Makes It Easier to Connect Critical AI and Cloud Services

    SaaS platform reduces friction and complexity across disparate platforms so enterprises and managed service providers can rapidly deploy communication services AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle today introduced the Oracle Intelligent Communications Orchestration Network Cloud Service. This next-generation solution is designed to radically simplify enterprise network configuration and operations by unifying fragmented communications environments through centralization and orchestration of network traffic and policy management— across voice, collaboration, AI, and other technologies running in on-premises, cloud, or hybrid environments. With this advancement, enterprises and m

    10/9/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Named a Leader in IDC MarketScape for Worldwide Corporate Loan Lifecycle Management

    Oracle brings global scale, comprehensive servicing capabilities, and GenAI-powered innovation to loan lifecycle process AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle has been named a Leader in the IDC MarketScape: Worldwide Corporate Loan Lifecycle Management 2025 Vendor Assessment. The report evaluated corporate loan lifecycle management vendors globally on their current capabilities and future strategies. According to the report, Oracle "offers AI, ML, and GenAI embedded in its solutions to improve customer experience and process efficiency. Among others, GenAI is leve

    10/9/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    Health Systems Simplify Secure Data Exchange with Oracle Health

    New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr

    10/9/25 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SoftBank Group to Acquire Ampere Computing

    SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

    3/19/25 7:30:00 PM ET
    $CG
    $ORCL
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Corporation Announces Promotion of Clay Magouyrk and Mike Sicilia to CEOs; Safra Catz Appointed Executive Vice Chair of the Board of Directors

    AUSTIN, Texas, Sept. 22, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the promotion of Clay Magouyrk and Mike Sicilia to the roles of Chief Executive Officers.  Clay Magouyrk, previously President, Oracle Cloud Infrastructure (OCI), joined Oracle in 2014 from Amazon Web Services. As a founding member of Oracle's cloud engineering team, Clay has overseen the design, implementation and business success of Gen2 of OCI. Oracle Cloud Infrastructure Gen2 is a high-performance, secure, cost-efficient platform that powers both hyperscale public cloud datacenters

    9/22/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Announces Fiscal Year 2026 First Quarter Financial Results

    Q1 Remaining Performance Obligations $455 billion, up 359% in both USD and constant currencyQ1 GAAP Earnings per Share down 2% to $1.01, Non-GAAP Earnings per Share up 6% to $1.47Q1 Total Revenue $14.9 billion, up 12% in USD and up 11% in constant currencyQ1 Cloud Revenue (IaaS plus SaaS) $7.2 billion, up 28% in USD and up 27% in constant currency Q1 Cloud Infrastructure (IaaS) Revenue $3.3 billion, up 55% in USD and up 54% in constant currency Q1 Cloud Application (SaaS) Revenue $3.8 billion, up 11% in USD and up 10% in constant currencyQ1 Fusion Cloud ERP (SaaS) Revenue $1.0 billion, up 17% in USD and up 16% in constant currencyQ1 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 16% in U

    9/9/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its First Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on September 9, 2025, After the Close of the Market AUSTIN, Texas, Sept. 2, 2025 /PRNewswire/ -- Oracle Corporation today announced that its first quarter fiscal year 2026 results will be released on Tuesday, September 9th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, auton

    9/2/25 4:01:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology